Skip to content
    AXSM stock page

    Axsome Therapeutics, Inc.

    AXSM · earnings call history

    2 calls analysed
    1. Jun 2026Q2 FY26Aug 10, 2026

      Axsome Therapeutics Q2 FY26 — Robust Commercial Growth and Pipeline Advancement

      Read the brief
    2. Mar 2026Q1 FY26May 04, 2026

      Axsome Therapeutics Q1 FY26 — AUVELITY Peak Sales Outlook Raised to $8B Following ADA Approval

      Read the brief

    Browse all US companies on the earnings-call register.